To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products.
Summary
What This Bill Does
The bill provides findings Congress finds the following: In April 2020, the Food and Drug Administration issued guidance entitled Enforcement Priorities for Electronic Nicotine Delivery System (ENDS) and Other Deemed Products on and provides updated enforcement prioritization. It relies on definition changes, appropriations, compliance mandates, and product standards. The main policy areas are Healthcare Consumers and Healthcare.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Public beneficiaries or protected communities affected by the clause could face increased risk.
Key Provisions
- Provides findings Congress finds the following: In April 2020, the Food and Drug Administration issued guidance entitled Enforcement Priorities for Electronic Nicotine Delivery System (ENDS) and Other Deemed Products on...
- Provides updated enforcement prioritization.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides findings Congress finds the following: In April 2020, the Food and Drug Administration issued guidance entitled Enforcement Priorities for Electronic Nicotine Delivery System (ENDS) and Other Deemed Products on and provides updated enforcement prioritization.
Key Policy Areas
Healthcare Consumers, Healthcare
Primary Purpose
The bill provides findings Congress finds the following: In April 2020, the Food and Drug Administration issued guidance entitled Enforcement Priorities for Electronic Nicotine Delivery System (ENDS) and Other Deemed Products on and provides updated enforcement prioritization.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Public beneficiaries or protected communities affected by the clause
Legislative Progress
IntroducedMrs. Cherfilus-McCormick introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology